# Nanalysis Scientific Corp. (NSCIF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NSCIF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 40.13M | $ -5.66M | $ 1.57M | $ 17.58M | $ 13.42M |
| 2024 | $ 46.36M | $ -13.87M | $ 1.43M | $ 18.36M | $ 15.55M |
| 2023 | $ 29.54M | $ -17.42M | $ -16.35M | $ 21.97M | $ 23.48M |
| 2022 | $ 26.63M | $ -10.20M | $ -16.69M | $ 10.75M | $ 35.13M |
| 2021 | $ 18.30M | $ -1.99M | $ -4.79M | $ 5.99M | $ 23.96M |
| 2020 | $ 9.41M | $ -4.47M | $ -4.21M | $ 3.78M | $ 14.34M |
| 2019 | $ 10.07M | $ -2.00M | $ -2.79M | $ 1.51M | $ 15.12M |
| 2018 | $ 10.32M | $ 104.1K | $ -1.24M | $ 997.0K | $ 8.39M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.31 |
| Liabilities / Eq | 1.86 |
| Current Ratio | 0.97 |

## Other views

- [Metrics](https://sponda.capital/en/NSCIF.md)
- [Charts](https://sponda.capital/en/NSCIF/charts.md)
- [Compare](https://sponda.capital/en/NSCIF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.
